PSTV - Plus Therapeutics GAAP EPS of -$0.59 beats by $1.44
2023-08-14 16:07:41 ET
More on Plus Therapeutics
- Plus stock rises as radiotherapy shows promise in ongoing brain cancer studies
- Plus Therapeutics Q3 net loss widens Y/Y
- Plus Therapeutics jumps 18% as JonesTrading adds another Buy rating
- Plus Therapeutics finalizes $17.6M grant from Texas, to get initial funds by October end
- Seeking Alpha’s Quant Rating on Plus Therapeutics
- Earnings data for Plus Therapeutics
For further details see:
Plus Therapeutics GAAP EPS of -$0.59 beats by $1.44